- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
- Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
- Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
- Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
- Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
- Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
- Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
More ▼
Key statistics
On Thursday, Mural Oncology PLC (MURA:NMQ) closed at 3.46, 20.14% above the 52 week low of 2.88 set on Jul 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.42 |
---|---|
High | 3.57 |
Low | 3.40 |
Bid | 3.42 |
Offer | 3.52 |
Previous close | 3.43 |
Average volume | 142.51k |
---|---|
Shares outstanding | 16.92m |
Free float | 16.52m |
P/E (TTM) | -- |
Market cap | 58.05m USD |
EPS (TTM) | -11.49 USD |
Data delayed at least 15 minutes, as of Jul 25 2024 21:00 BST.
More ▼